Phillip K. Pellitteri

Author

Also Known As

P. K. Pellitteri, Pellitteri, Phillip K., Phillip K Pellitteri, Phillip K. Pellitteri, Phillip K. Pellitteri DO, Phillip Kevin Pellitteri

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Geisinger Medical Center

About

Phillip K. Pellitteri is an author at Geisinger Medical Center specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	216
2	Cell Biology	2	2	94
3	Health Sciences	1	1	87
4	Emergency Medicine	1	1	12
5	Otolaryngology	1	1	12

Phillip K. Pellitteri

Publications

548

Citations

H-Index

Page 1

	Year	Citations
Expanded application of selective neck dissection with regard to nodal status Phillip K. Pellitteri, K. Thomas Robbins, Thomas R. Neuman Head & Neck	1997	115
Radiotherapy: The Mainstay in the Treatment of Early Glottic Carcinoma Phillip K. Pellitteri, T. L. Kennedy, Donald P. Vrabec, Archives of Otolaryngology - Head and Neck Surgery Adaptive RadiotherapyRadiation MedicineSurgical OncologyPrimary Conservation SurgeryRadiation Therapy	1991	87
Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis Ping L. Zhang, Phillip K. Pellitteri, Amy Law, Modern Pathology OncologyHigh-grade DysplasiaMedicinePathologyPoor Prognosis	2005	62
Thyroid Carcinoma in Children and Adolescents Brad Millman, Phillip K. Pellitteri Archives of Otolaryngology - Head and Neck Surgery	1995	53
Use of a Rapid Intraoperative Parathyroid Hormone Assay in the Surgical Management of Parathyroid Disease Pranay Patel, Phillip K. Pellitteri, Niketu M. Patel, Archives of Otolaryngology - Head and Neck Surgery	1998	50
Nuclear factor-kappaB pathway as a therapeutic target in head and neck squamous cell carcinoma: pharmaceutical and molecular validation in human cell lines using Velcade and siRNA/NF-kappaB. Mingyue Lun, Ping L. Zhang, Phillip K. Pellitteri, PubMed	2005	37
Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma. Robert Brown, Ping L. Zhang, Mingyue Lun, PubMed Squamous Cell CarcinomaPathologyPharmacoproteomic RationaleCancer BiologyTumor Biology	2006	32
The Influence of Intensive Hyperbaric Oxygen Therapy on Skin Flap Survival in a Swine Model Phillip K. Pellitteri, T. L. Kennedy, Brian A. Youn Archives of Otolaryngology - Head and Neck Surgery	1992	29
Factors Related to Outcome of Salvage Therapy for Isolated Cervical Recurrence of Squamous Cell Carcinoma in the Previously Treated Neck: A Multi‐Institutional Study Bryan J. Krol, Paul D. Righi, Joseph A. Paydarfar, Otolaryngology	2000	20
Assessing the impact of low baseline parathyroid hormone levels on surgical treatment of primary hyperparathyroidism Michelle Clark, Phillip K. Pellitteri The Laryngoscope	2009	16

Page 1